Management of Leukocytes Without Nitrites in a Patient on Prophylactic Nitrofurantoin
Continue the prophylactic nitrofurantoin without treatment changes if the patient is asymptomatic. The presence of leukocytes without nitrites in this clinical scenario most likely represents asymptomatic bacteriuria (ASB), which should not be treated 1.
Understanding the Clinical Picture
Why Nitrites May Be Negative
The absence of nitrites on dipstick does not rule out bacteriuria in patients on nitrofurantoin prophylaxis. Nitrofurantoin itself can reduce the sensitivity of the nitrite strip reaction 2. Additionally, the dark urine color is an expected side effect—nitrofurantoin is highly soluble in urine and may impart a brown color 3.
The Dipstick Has Limited Value Here
In patients with indwelling catheters or on chronic prophylaxis, urinalysis has very low specificity for diagnosing true UTI 4. The presence of leukocytes alone is not diagnostic of infection requiring treatment. Pyuria (leukocytes in urine) is extremely common in patients on prophylactic antibiotics and often represents colonization rather than active infection.
Decision Algorithm
If the patient is asymptomatic:
- Do not obtain a urine culture 1
- Do not treat with antibiotics 5
- Continue prophylactic nitrofurantoin as prescribed
- Reassure the patient that dark urine is an expected medication effect 3
If the patient has symptoms (dysuria, frequency, urgency, suprapubic pain):
- Obtain a urine culture before initiating treatment 1
- Consider this a breakthrough UTI on prophylaxis
- Switch to a different antibiotic for treatment (not nitrofurantoin, as breakthrough suggests possible resistance or inadequate prophylaxis)
- After treatment, reassess the prophylactic regimen
Key Evidence Supporting This Approach
The 2024 EAU guidelines explicitly state that routine post-treatment urinalysis or urine cultures are not indicated for asymptomatic patients 1. The 2019 IDSA guidelines on asymptomatic bacteriuria provide strong recommendations against screening for or treating ASB in non-pregnant, premenopausal women, as there is no evidence that treatment prevents symptomatic UTI, and high-quality evidence demonstrates harm from unnecessary antibiotics 5.
Common Pitfalls to Avoid
- Do not reflexively treat based on dipstick findings alone in asymptomatic patients—this leads to unnecessary antibiotic exposure, adverse effects, and promotes resistance
- Do not obtain urine cultures in asymptomatic patients—bacteriuria is expected in many patients on prophylaxis and does not require treatment
- Do not interpret dark urine as hematuria or infection—this is a known, benign effect of nitrofurantoin 3
- Do not assume nitrite negativity rules out bacteriuria in patients on nitrofurantoin, as the drug interferes with the test 2
When to Reassess the Prophylactic Strategy
If the patient develops recurrent symptomatic breakthrough UTIs despite prophylaxis, consider:
- Switching to an alternative prophylactic agent (trimethoprim-sulfamethoxazole, methenamine hippurate, or postcoital prophylaxis) 1
- Non-antimicrobial preventive measures (vaginal estrogen in postmenopausal women, increased fluid intake, cranberry products, D-mannose) 1
- Evaluating for anatomic abnormalities if breakthrough infections are frequent
The current presentation with leukocytes but no symptoms does not warrant any change in management.